Last reviewed · How we verify
AZD0284
At a glance
| Generic name | AZD0284 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis (PHASE1)
- Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects (PHASE1)
- Bioavailability of AZD0284 and IV Microtracer Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AZD0284 CI brief — competitive landscape report
- AZD0284 updates RSS · CI watch RSS
- AstraZeneca portfolio CI